Evidence for a clonally different origin of the two cholera epidemics of 2001–2002 and 1980–1987 in South Africa

References

1. Colwell R. R., Spira W. M. 1992; The ecology of Vibrio cholerae . In Cholera pp 107–127 Edited by Barua D., Greenough W. B. III New York: Plenum;
   [Google Scholar]
2. Dalsgaard A., Forslund A., Sandvang D., Arntzen L., Keddy K. 2001; Vibrio cholerae O1 outbreak isolates in Mozambique in 1998 are multiple drug resistant, contain the SXT element and the aadA2 gene located on class 1 integrons. J Antimicrob Chemother 48:827–838 [CrossRef]
   [Google Scholar]
3. Garg P., Nandy R. J., Chaudury P., Chowdhury N. R., De K., Ramamurthy T., Yamasaki S., Bhattacharya S. K., Takeda Y., Nair G. B. 2000; Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba from the prevailing O1 Ogawa serotype strains in India. J Clin Microbiol 38:4249–4253
   [Google Scholar]
4. Ito T., Hiramatsu K., Ohshita Y., Yokota T. 1993; Mutations in the rfbT gene are responsible for the Ogawa to Inaba serotype conversion in Vibrio cholerae O1. Microbiol Immunol 37:281–288 [CrossRef]
   [Google Scholar]
5. Küstner H. G. V., Du Plessis G. 1991; The cholera epidemic in South Africa, 1980–1987. Epidemiological features. S Afr Med J 79:539–544
   [Google Scholar]
6. Lucas M. E. S., Deen J. L., von Seidlen L., Wang X.-Y., Ampuero J., Puri M., Ali M., Ansaruzzaman M., Amos J. other authors 2005; Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352:757–767 [CrossRef]
   [Google Scholar]
7. Manning P. A., Stroeher U. H., Morona R. 1994; Molecular basis for O-antigen biosynthesis in Vibrio cholerae O1: Ogawa-Inaba switching. . In Vibrio cholerae and Cholera: Molecular to Global Perspectives pp 77–92 Edited by Wachsmuth I. K., Blake P. A, Olsvik Ø. Washington, DC: American Society for Microbiology;
   [Google Scholar]
8. Mekalanos J. J., Swartz D. J., Pearson G. D., Harford N., Groyne F., de Wilde M. 1983; Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 306:551–557 [CrossRef]
   [Google Scholar]
9. Reeves P. R., Hobbs M., Valvano M. A., Skurnik M., Whitfield C., Coplin D., Kido N., Klena J., Maskell D. other authors 1996; Bacterial polysaccharide synthesis and gene nomenclature. Trends Microbiol 4:495–503 [CrossRef]
   [Google Scholar]
10. Sack R. B., Miller C. E. 1969; Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae . J Bacteriol 99:688–695
    [Google Scholar]
11. Sheehy T. W., Sprinz H., Augurson W. S., Formal S. B. 1966; Laboratory Vibrio cholerae infection in the United States. JAMA 197:321–326 [CrossRef]
    [Google Scholar]
12. Stroeher U. H., Karageorgos L. E., Morona R., Manning P. A. 1992; Serotype conversion in Vibrio cholerae O1. Proc Natl Acad Sci U S A 89:2566–2570 [CrossRef]
    [Google Scholar]
13. Swerdlow D. L., Isaäcson M. 1994; The epidemiology of cholera in Africa. In Vibrio cholerae and Cholera: Molecular to Global Perspectives . pp 297–307 Edited by Wachsmuth I. K., Blake P. A, Olsvik Ø. Washington, DC: American Society for Microbiology;
14. Wachsmuth I. K., Evins G. M., Fields P., Olvik O., Popovic T., Bopp C. A., Wells J. G., Carillo C., Blake P. A. 1993; The molecular epidemiology of cholera in Latin America. J Infect Dis 167:621–626 [CrossRef]
    [Google Scholar]